Literature DB >> 26862465

Challenges and Opportunities in Drug Delivery for Wound Healing.

Alexander J Whittam1, Zeshaan N Maan1, Dominik Duscher1, Victor W Wong2, Janos A Barrera1, Michael Januszyk1, Geoffrey C Gurtner1.   

Abstract

Significance: Chronic wounds remain a significant public health problem. Alterations in normal physiological processes caused by aging or diabetes lead to impaired tissue repair and the development of chronic and nonhealing wounds. Understanding the unique features of the wound environment will be required to develop new therapeutics that impact these disabling conditions. New drug-delivery systems (DDSs) may enhance current and future therapies for this challenging clinical problem. Recent Advances: Historically, physical barriers and biological degradation limited the efficacy of DDSs in wound healing. In aiming at improving and optimizing drug delivery, recent data suggest that combinations of delivery mechanisms, such as hydrogels, small molecules, RNA interference (RNAi), as well as growth factor and stem cell-based therapies (biologics), could offer exciting new opportunities for improving tissue repair. Critical Issues: The lack of effective therapeutic approaches to combat the significant disability associated with chronic wounds has become an area of increasing clinical concern. However, the unique challenges of the wound environment have limited the development of effective therapeutic options for clinical use. Future Directions: New platforms presented in this review may provide clinicians and scientists with an improved understanding of the alternatives for drug delivery in wound care, which may facilitate the development of new therapeutic approaches for patients.

Entities:  

Year:  2016        PMID: 26862465      PMCID: PMC4742986          DOI: 10.1089/wound.2014.0600

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  48 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

2.  Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α.

Authors:  Curtis A Thorne; Alison J Hanson; Judsen Schneider; Emilios Tahinci; Darren Orton; Christopher S Cselenyi; Kristin K Jernigan; Kelly C Meyers; Brian I Hang; Alex G Waterson; Kwangho Kim; Bruce Melancon; Victor P Ghidu; Gary A Sulikowski; Bonnie LaFleur; Adrian Salic; Laura A Lee; David M Miller; Ethan Lee
Journal:  Nat Chem Biol       Date:  2010-10-03       Impact factor: 15.040

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies.

Authors:  J M Smiell; T J Wieman; D L Steed; B H Perry; A R Sampson; B H Schwab
Journal:  Wound Repair Regen       Date:  1999 Sep-Oct       Impact factor: 3.617

5.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Authors:  Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

6.  Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.

Authors:  J R Hanft; R A Pollak; A Barbul; C van Gils; P S Kwon; S M Gray; C J Lynch; C P Semba; T J Breen
Journal:  J Wound Care       Date:  2008-01       Impact factor: 2.072

7.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

Review 8.  Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.

Authors:  Dana J Gary; Nitin Puri; You-Yeon Won
Journal:  J Control Release       Date:  2007-05-26       Impact factor: 9.776

9.  Human adipose stromal vascular cell delivery in a fibrin spray.

Authors:  Ludovic Zimmerlin; J Peter Rubin; Melanie E Pfeifer; Linda R Moore; Vera S Donnenberg; Albert D Donnenberg
Journal:  Cytotherapy       Date:  2013-01       Impact factor: 5.414

Review 10.  Advanced materials and processing for drug delivery: the past and the future.

Authors:  Ying Zhang; Hon Fai Chan; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

View more
  18 in total

Review 1.  A review of accelerated wound healing approaches: biomaterial- assisted tissue remodeling.

Authors:  Shirin Nour; Nafiseh Baheiraei; Rana Imani; Mohammad Khodaei; Akram Alizadeh; Navid Rabiee; S Mohammad Moazzeni
Journal:  J Mater Sci Mater Med       Date:  2019-10-19       Impact factor: 3.896

2.  Multidomain Peptide Hydrogel Accelerates Healing of Full-Thickness Wounds in Diabetic Mice.

Authors:  Nicole C Carrejo; Amanda N Moore; Tania L Lopez Silva; David G Leach; I-Che Li; Douglas R Walker; Jeffrey D Hartgerink
Journal:  ACS Biomater Sci Eng       Date:  2018-03-16

3.  Food and Drug Administration perspective: Advancing product development for non-healing chronic wounds.

Authors:  Kapil Dev Verma; Felisa Lewis; Maryjoy Mejia; Meghana Chalasani; Kendall A Marcus
Journal:  Wound Repair Regen       Date:  2022-04-06       Impact factor: 3.401

4.  Sox9 and Rbpj differentially regulate endothelial to mesenchymal transition and wound scarring in murine endovascular progenitors.

Authors:  Jilai Zhao; Jatin Patel; Simranpreet Kaur; Seen-Ling Sim; Ho Yi Wong; Cassandra Styke; Isabella Hogan; Sam Kahler; Hamish Hamilton; Racheal Wadlow; James Dight; Ghazaleh Hashemi; Laura Sormani; Edwige Roy; Mervin C Yoder; Mathias Francois; Kiarash Khosrotehrani
Journal:  Nat Commun       Date:  2021-05-07       Impact factor: 14.919

Review 5.  Approaches to Modulate the Chronic Wound Environment Using Localized Nucleic Acid Delivery.

Authors:  Adam G Berger; Jonathan J Chou; Paula T Hammond
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-07-07       Impact factor: 4.947

6.  Electromechanically Actuated Multifunctional Wireless Auxetic Device for Wound Management.

Authors:  Mariam Mir; Umar Ansari; Murtaza Najabat Ali; Muhammad Hassan Ul Iftikhar; Faisal Qayyum
Journal:  IEEE J Transl Eng Health Med       Date:  2017-12-04       Impact factor: 3.316

Review 7.  Nanotechnology-Driven Therapeutic Interventions in Wound Healing: Potential Uses and Applications.

Authors:  Suzana Hamdan; Irena Pastar; Stefan Drakulich; Emre Dikici; Marjana Tomic-Canic; Sapna Deo; Sylvia Daunert
Journal:  ACS Cent Sci       Date:  2017-02-27       Impact factor: 14.553

8.  Does antibiotic use accelerate or retard cutaneous repair? A systematic review in animal models.

Authors:  Luciana Schulthais Altoé; Raul Santos Alves; Mariáurea Matias Sarandy; Mônica Morais-Santos; Rômulo Dias Novaes; Reggiani Vilela Gonçalves
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

Review 9.  Stimuli-Responsive Delivery of Growth Factors for Tissue Engineering.

Authors:  Moyuan Qu; Xing Jiang; Xingwu Zhou; Canran Wang; Qingzhi Wu; Li Ren; Jixiang Zhu; Songsong Zhu; Peyton Tebon; Wujin Sun; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2020-03-03       Impact factor: 9.933

10.  Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing.

Authors:  Jun Ishihara; Ako Ishihara; Kazuto Fukunaga; Koichi Sasaki; Michael J V White; Priscilla S Briquez; Jeffrey A Hubbell
Journal:  Nat Commun       Date:  2018-06-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.